JP2012500016A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500016A5
JP2012500016A5 JP2011523422A JP2011523422A JP2012500016A5 JP 2012500016 A5 JP2012500016 A5 JP 2012500016A5 JP 2011523422 A JP2011523422 A JP 2011523422A JP 2011523422 A JP2011523422 A JP 2011523422A JP 2012500016 A5 JP2012500016 A5 JP 2012500016A5
Authority
JP
Japan
Prior art keywords
antibody
mcp
seq
inhibitor
n1pe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011523422A
Other languages
English (en)
Japanese (ja)
Other versions
JP5819194B2 (ja
JP2012500016A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/060757 external-priority patent/WO2010020669A1/en
Publication of JP2012500016A publication Critical patent/JP2012500016A/ja
Publication of JP2012500016A5 publication Critical patent/JP2012500016A5/ja
Application granted granted Critical
Publication of JP5819194B2 publication Critical patent/JP5819194B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011523422A 2008-08-20 2009-08-20 ピログルタミン酸化単球走化性タンパク質−1(MCP−1N1pE)に対する抗体 Expired - Fee Related JP5819194B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9026408P 2008-08-20 2008-08-20
US61/090,264 2008-08-20
PCT/EP2009/060757 WO2010020669A1 (en) 2008-08-20 2009-08-20 Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe)

Publications (3)

Publication Number Publication Date
JP2012500016A JP2012500016A (ja) 2012-01-05
JP2012500016A5 true JP2012500016A5 (https=) 2012-10-04
JP5819194B2 JP5819194B2 (ja) 2015-11-18

Family

ID=41259004

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011523422A Expired - Fee Related JP5819194B2 (ja) 2008-08-20 2009-08-20 ピログルタミン酸化単球走化性タンパク質−1(MCP−1N1pE)に対する抗体

Country Status (12)

Country Link
US (3) US8518406B2 (https=)
EP (1) EP2328930B1 (https=)
JP (1) JP5819194B2 (https=)
AU (1) AU2009284092B2 (https=)
CA (1) CA2734800C (https=)
DK (1) DK2328930T3 (https=)
ES (1) ES2533493T3 (https=)
IL (1) IL210866A (https=)
NZ (1) NZ591187A (https=)
PL (1) PL2328930T3 (https=)
WO (1) WO2010020669A1 (https=)
ZA (1) ZA201100658B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103382174A (zh) 2006-06-23 2013-11-06 雅培制药有限公司 作为组胺h3受体调节物的环丙胺衍生物
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
EP2537029A1 (en) * 2010-02-18 2012-12-26 Probiodrug AG Methods of diagnosing inflammatory diseases by determining pyroglutamate-modified mcp-1 and screening methods for inhibitors of glutaminyl cyclase
US8853390B2 (en) 2010-09-16 2014-10-07 Abbvie Inc. Processes for preparing 1,2-substituted cyclopropyl derivatives
RU2476880C1 (ru) * 2011-08-25 2013-02-27 Российская Федерация, От Имени Которой Выступает Министерство Образования И Науки Российской Федерации Способ диагностики гестоза тяжелой степени
WO2015085171A1 (en) * 2013-12-06 2015-06-11 Adventist Health Systems/Sunbelt, Inc. Role of mcp-1 in relapse of acute myeloid leukemia after hematopoietic stem cell transplantation
US10610104B2 (en) 2016-12-07 2020-04-07 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
CA3045310A1 (en) 2016-12-14 2018-06-21 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
US20220249814A1 (en) 2018-11-19 2022-08-11 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
CN121197633A (zh) 2019-12-13 2025-12-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
WO2023213400A1 (en) * 2022-05-05 2023-11-09 Institute For Research In Biomedicine Antibodies against chemokines, method for identifying said antibodies and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4504733A (en) * 1984-05-15 1985-03-12 Sybron Corporation Dry bath temperature control
US5229580A (en) * 1992-06-09 1993-07-20 Automated Biosystems, Inc. Block for holding multiple sample tubes for automatic temperature control
US6191398B1 (en) * 1999-09-10 2001-02-20 Barnstead/Thermolyne Corporation Dry bath temperature control and method
WO2001089582A1 (en) 2000-05-26 2001-11-29 Takeda Chemical Industries, Ltd. Preventives and remedies for pulmonary hypertension
GB0016138D0 (en) 2000-06-30 2000-08-23 Novartis Ag Organic compounds
US7381801B2 (en) * 2002-02-13 2008-06-03 Ludwig Institute For Cancer Research Chimerized GM-CSF antibodies
US20040001828A1 (en) * 2002-02-21 2004-01-01 Joseph Tuscano Treatment methods using anti-CD22 antibodies
CA2496419A1 (en) * 2002-08-19 2004-02-26 Abgenix, Inc. Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
KR20050042801A (ko) 2002-09-12 2005-05-10 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 인간형 항인간 mcp-1 항체 및 그의 항체 단편
PE20061444A1 (es) * 2005-05-19 2007-01-15 Centocor Inc Anticuerpo anti-mcp-1, composiciones, metodos y usos
WO2006125201A2 (en) 2005-05-19 2006-11-23 Centocor, Inc. Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
RU2429244C2 (ru) * 2006-03-23 2011-09-20 Байоарктик Ньюросайенс Аб Улучшенные селективные в отношении протофибрилл антитела и их применение
US20080056957A1 (en) * 2006-09-01 2008-03-06 Chemglass, Inc. Segmented reaction blocks for supporting vials of different sizes for chemical synthesis on a hot plate stirrer

Similar Documents

Publication Publication Date Title
JP2012500016A5 (https=)
CN108034005B (zh) 识别Tau的磷酸化特异抗体
JP2005515963A5 (https=)
US11286312B2 (en) Multispecific antibodies
JP2005516958A5 (https=)
US20170327579A1 (en) Bispecific antibodies against cd3epsilon and bcma
AU2013370009B2 (en) Anti-granulysin antibodies and methods of use thereof
JP2020518248A5 (https=)
WO2015191934A2 (en) Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
JP2022538926A (ja) Ranタンパク質関連神経学的疾患を処置するための方法
HRP20120477T1 (hr) Nova anti plgf protutijela
JP5819194B2 (ja) ピログルタミン酸化単球走化性タンパク質−1(MCP−1N1pE)に対する抗体
WO2016020332A1 (en) Bispecific antibodies against cd3epsilon and bcma
HRP20171190T1 (hr) Protutijelo protiv beta-amiloida i njegove upotrebe
JP2013500940A5 (https=)
JP2009518005A5 (https=)
JP2020514277A (ja) プログラム死リガンド−1(pd−l1)に結合する抗体を使用する免疫
HK1219512A1 (zh) 用於诊断和治疗炎性肠病的方法
CN111183157A (zh) Cd138抗体分子及其用途
JP7011939B2 (ja) ヒト抗-fgfr4抗体
JP2016501877A5 (https=)
JP2014509860A5 (https=)
US20210332145A1 (en) Anti-bcma antibodies
IL186509A (en) Reagents that bind ccx-ckr2
US20170260259A1 (en) Monoclonal antibody against muramyl peptides